VivoSeq
Oncology

Oncology Patients

0

Pipeline Programs

6

Active Trials

0

Companies Involved

Oncology Patients is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

63/100

Attrition Rate

18/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

17

clinical trials

Completed5 · 29%
Terminated3 · 18%
Recruiting3 · 18%
Unknown status3 · 18%
Active, not recruiting2 · 12%
Not yet recruiting1 · 6%

Trial Activity

17 trials

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients
Completed··Phase 2·NCT00042328·30 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)